With regulations ever changing and the innovative advancements of technology rapidly growing, ICON’s team at #OCTSoCal will address the key clinical development challenges in pharma, biotech and medical devices. Come by booth #26 on 24 – 25 September to meet the team. https://ow.ly/IBrz50T9r8M
About us
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
- Website
-
http://www.iconplc.com
External link for ICON plc
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Dublin
- Type
- Public Company
- Specialties
- Medical Device, Therapeutics, Government and Public Health Solutions, Clinical Research Services, Commercialisation and Outcomes, Oncology, Value Based Healthcare, Clinical Trials, Patient Recruitment, Innovation, Regulatory Affairs, Strategic Consulting, Medical Affairs, and Global Patient Insights & Engagement
Locations
Employees at ICON plc
Updates
-
Madelaine MacKay will have the opportunity to address globalization challenges in digital health technologies implementation at the#MobileinClinicalTrials this September 16 at 4:40pm. Join her session at the Loews Philadelphia Hotel. https://ow.ly/WQfn50T1Ko9
-
ICON’s Donald Palme II moderates a panel on new frontiers in electrophysiology from rhythm management to stroke prophylactic devices at Octane’s CTF 2024. Learn more on September 13, 1pm PST. https://ow.ly/Gvma50T20nL #CTF2024 #CardiovascularInnovation #CardiovascularTech
-
Our ISO 18587 certification helps ensure consistency and quality in the post-editing process, fostering trust and confidence in machine-translated content across various industries and applications. Read our blog on machine translation and how to ensure best practices in post-editing. https://ow.ly/hfqy50SXxeZ
-
ICON is taking part in a Bioanalysis Zone panel discussion to discuss key developments within the field of immunogenicity. During this session Robert Kernstock and other industry experts will discuss the challenges associated with immunogenicity testing, the factors to consider when developing immunogenicity assays, and how to overcome regulatory guidance hurdles. Register: https://ow.ly/8wCx50Tf1T0 #immunogenicity
-
ICON is a proud supporter of #ChildhoodCancerAwarenessMonth. Every 3 minutes a family hears the devastating words that their child has been diagnosed with cancer. Learn how ICON has been supporting research in #childhoodcancer and other #paediatric diseases. https://ow.ly/HXPX50T9BPt #ChildhoodCancer
-
Listen to our latest Bioanalysis Zone podcast where we discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs), industry best practices for achieving high-quality ADA assays, and the advantages and limitations of singlicate ADA analysis compared with alternative techniques. We also discuss the emerging trends in the field of immunogenicity and how they may shape the future of therapeutic protein development. https://ow.ly/8HY950SFNjZ #immunogenicity
-
We're thrilled to announce that ICON has been named a winner of the HireVue Customer Excellence Award for Unlocking Potential! This recognition highlights our commitment to leveraging innovative technology to identify and nurture talent. By using HireVue's cutting-edge solutions, we're able to tap into the full spectrum of our candidates' potential, ensuring we build teams that drive innovation in clinical research. Take the next step in your career with ICON today: https://ow.ly/gAVS50Tf4eO
-
Meet the ICON team at #LSIEurope24 to discover how we support, drive and accelerate the commercialisation of medical devices and diagnostics. https://ow.ly/mqR950TaJt8 #Medtech #MedTechInnovation #Medicaldevices
-
Meet the ICON Biotech team at #ESMO24, booth #423 to learn how we’re partnering with biotechnology organisations to provide industry-recognised, scientific leadership and consulting to plan and deliver oncology clinical trials, from small molecules to biologics, combination products, devices, ATMPs and companion diagnostics. https://ow.ly/XEhe50T2NfM